Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
33.77
+0.24 (0.72%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Harmony Biosciences Holdings Employees
Harmony Biosciences Holdings had 293 employees as of December 31, 2025. The number of employees increased by 25 or 9.33% compared to the previous year.
Employees
293
Change (1Y)
25
Growth (1Y)
9.33%
Revenue / Employee
$3,068,625
Profits / Employee
$496,980
Market Cap
1.96B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | 25 | 9.33% |
| Dec 31, 2024 | 268 | 22 | 8.94% |
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| AbCellera Biologics | 562 |
| Lakefront Biotherapeutics NV | 558 |
| Ocular Therapeutix | 325 |
| UroGen Pharma | 298 |
| Viridian Therapeutics | 252 |
| Kardigan | 241 |
| Monte Rosa Therapeutics | 187 |
HRMY News
- 2 days ago - Harmony Biosciences Preannounces Record Quarterly Revenue for Q2 2026, Reaffirms Full-Year 2026 Revenue Guidance, and Announces CFO Transition - Business Wire
- 18 days ago - Harmony Biosciences price target raised to $36 from $30 at Deutsche Bank - TheFly
- 4 weeks ago - 20 growth stocks priced as value stocks - Market Watch
- 5 weeks ago - Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting - Business Wire
- 5 weeks ago - Harmony Biosciences Holdings Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Harmony Biosciences to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Harmony Biosciences Holdings Transcript: AGM 2026 - Transcripts
- 2 months ago - Harmony Biosciences price target raised to $29 from $25 at Truist - TheFly